<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>22</Volume>
				<Issue>8</Issue>
				<PubDate PubStatus="epublish">
					<Year>2021</Year>
					<Month>08</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Tumor-Derived Matrix Metalloproteinase-13 (MMP-13) Expression in Benign and Malignant Breast Lesions</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2603</FirstPage>
			<LastPage>2609</LastPage>
			<ELocationID EIdType="pii">89732</ELocationID>
			
<ELocationID EIdType="doi">10.31557/APJCP.2021.22.8.2603</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Fereshteh </FirstName>
					<LastName>Ameli</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex,Tehran University of Medical Sciences, Tehran, Iran. </Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Firouzeh </FirstName>
					<LastName>Ghafourina Nassab</LastName>
<Affiliation>Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>

</Author>
<Author>
					<FirstName>Noraidah </FirstName>
					<LastName>Masir</LastName>
<Affiliation>Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>

</Author>
<Author>
					<FirstName>Farzan </FirstName>
					<LastName>Kahtib</LastName>
<Affiliation>Department of Electrical Engineering, Mashhad Branch, Islamic Azad University, Mashhad, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2021</Year>
					<Month>05</Month>
					<Day>26</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Breast carcinoma is the most common malignancy and the leading cause of cancer death in women. Matrix metalloproteinase-13 (MMP-13) is a hypothetical prognostic marker in invasive breast cancer. This study aimed to determine MMP-13 expression in benign and malignant breast lesions and to evaluate the correlation between MMP-13 expression and tumor characteristics in invasive ductal carcinoma (IDC). Materials and Method: We evaluated cytoplasmic expression of MMP-13 based on staining index using immunohistochemistry (IHC) in epithelial cells, stromal fibroblasts of IDC (n=90) and benign epithelial breast (n=90) lesions. Correlation between IHC and tumor size, lymph node status, distance metastasis, estrogen receptor (ER), progesterone receptor (PR) and Her-2/neu was assessed. Results: MMP-13 expression was 45% and 38.8% in malignant epithelial cells and peritumoral fibroblasts, respectively. Only low level of MMP-13 expression was seen in benign breast lesions (8.8% in epithelial component and 2.2% in stromal fibroblasts), while high level of MMP-13 expression was noted in malignant tumors, mainly grade II or III. Cytoplasmic MMP-13 expressions in epithelial tumor cells was correlated significantly with peritumoral fibroblasts. MMP-13 expression was directly correlated with distant metastasis and tumor stage in epithelial tumoral cells and was inversely correlated with progesterone expression in both tumoral and stromal cells. Conclusion: This study showed that MMP-13 was a moderator for tumor invasion and metastasis and could be an independent predictor of poor prognosis in breast cancer. The role of MMP-13 in predicting the risk of malignant transformation in benign lesions should be further investigated.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Matrix metalloproteinase 13 (MMP-13)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognostic marker</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_89732_37f3f138d6e6d9cd7ef841ca47a44cbb.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
